END STAGE AIDS

END STAGE AIDS was reported 28 times

END STAGE AIDS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 1 0.0008
1 CCR5 Co-receptor Antagonist [EPC] 1 0.0004
2 Antimalarial [EPC] 4 0.0004
3 Antiprotozoal [EPC] 4 0.0004
4 Sulfonamide Antibacterial [EPC] 1 0.0003
5 Cannabinoid [EPC] 2 0.0002
6 Protease Inhibitor [EPC] 6 0.0001
7 Quinolone Antimicrobial [EPC] 1 0.0001
8 Cytochrome P450 3A Inhibitor [EPC] 6 0.0001
9 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0001
10 Bile Acid Sequestrant [EPC] 1 0.0001
11 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
12 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
13 Polyene Antifungal [EPC] 2 0.0000
14 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5 0.0000
15 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
16 Azole Antifungal [EPC] 7 0.0000
17 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 3 0.0000
18 Nitroimidazole Antimicrobial [EPC] 2 0.0000
19 Rifamycin Antibacterial [EPC] 1 0.0000
20 Macrolide Antimicrobial [EPC] 1 0.0000
21 Glycopeptide Antibacterial [EPC] 1 0.0000
22 Cardiac Glycoside [EPC] 1 0.0000
23 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
24 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
25 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
26 alpha-Adrenergic Blocker [EPC] 1 0.0000
27 Vitamin D [EPC] 2 0.0000
28 Aldosterone Antagonist [EPC] 1 0.0000
29 Vitamin B12 [EPC] 2 0.0000
30 Vitamin C [EPC] 2 0.0000
31 Osmotic Laxative [EPC] 1 0.0000
32 beta-Adrenergic Blocker [EPC] 1 0.0000
33 Corticosteroid [EPC] 4 0.0000
34 Loop Diuretic [EPC] 1 0.0000
35 Benzodiazepine [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000